Starling Oncology (STLN) Net Cash Flow Growth (1y) (2021 - 2026)
Powered by 
Analysis
Starling Oncology (STLN) Net Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | 156.92% |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | -113.10% |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | -304.79% |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | -90.20% |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | 27.26% |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | -440.94% |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | -69.26% |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | -1,475.56% |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | 342.67% |
| 10 | Starling Oncology | 609.95 Mn | 568.85 Mn | 27.17 Mn | 214.47% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 214.47% |
| Mar 31, 2026 | 66.92% |
| Dec 31, 2025 | 183.85% |
| Sep 30, 2025 | -123.99% |
| Jun 30, 2025 | -2,660.16% |
| Mar 31, 2025 | -486.83% |
| Dec 31, 2024 | -65.04% |
| Sep 30, 2024 | 908.99% |
| Jun 30, 2024 | -97.30% |
| Mar 31, 2024 | 107.02% |
| Dec 31, 2023 | 112.56% |
| Sep 30, 2023 | 51.24% |
| Jun 30, 2023 | 143.55% |
| Mar 31, 2023 | 106.31% |
| Dec 31, 2022 | -145.75% |
| Sep 30, 2022 | 23.48% |
| Jun 30, 2022 | -155.87% |
| Mar 31, 2022 | -191.72% |
| Dec 31, 2021 | 3,919.58% |
| Sep 30, 2021 | -3,379.02% |